Lamotrigine for cognitive deficits associated with neurofibromatosis type 1: A phase II randomized placebo‐controlled trial
Year: 2024
Type: article
Abstract: onlinelibrary.wiley.com
DOI: 10.1111/dmcn.16157
Language: English
Subfield: Neurology
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
OpenAlex ID: W4403790761
